Literature DB >> 30117565

Migraine and cerebrovascular diseases: Epidemiology, pathophysiological, and clinical considerations.

João Eudes Magalhães1,2, Pedro Augusto Sampaio Rocha-Filho3,4.   

Abstract

Migraine and cerebrovascular diseases are disabling disorders, which are possibly closely interrelated. Heterogeneous and scattered evidence in literature remains a challenge. We searched for systematic reviews including diverse cerebrovascular events in migraineurs and reported relevant original studies to update the evidence when necessary. The studies show that migraine is associated with increased risk of transient ischemic attacks, any stroke, and possibly hemorrhagic stroke. In addition, migraine with aura increases the risk of ischemic stroke and white matter abnormalities. Migraine without aura increases the risk of cervical artery dissection as a cause of ischemic stroke. Groups with specific risk profiles are women, young people, smokers, and oral contraceptive users. The pathophysiology of the association remains uncertain. However, genetic and environmental factors may be involved in intricate mechanisms responsible for oxidative stress, vascular dysfunction and, ultimately, vascular events. In conclusion, migraine is a potential risk factor for cerebrovascular diseases. Migraineurs should be carefully evaluated considering their vascular risk assessment based on current evidence, so that healthcare professionals can provide appropriate and individualized management of other cardiovascular risk factors, notably quitting smoking and restricting use of oral contraceptives.
© 2018 American Headache Society.

Entities:  

Keywords:  cerebrovascular disorders; ischemic attack; migraine with aura; migraine without aura; stroke; transient

Mesh:

Year:  2018        PMID: 30117565     DOI: 10.1111/head.13378

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  8 in total

1.  Association Between Insomnia and Migraine Risk: A Case-Control and Bidirectional Mendelian Randomization Study.

Authors:  Shujuan Chu; Zhilin Wu; Zhouyang Wu; Jing Wu; Yue Qian
Journal:  Pharmgenomics Pers Med       Date:  2021-08-13

2.  Calcitonin gene-related peptide-targeting drugs and Raynaud's phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database.

Authors:  Michel Lantéri-Minet; Milou-Daniel Drici; Alexandre O Gérard; Diane Merino; Elise K Van Obberghen; Fanny Rocher; Alexandre Destere
Journal:  J Headache Pain       Date:  2022-05-03       Impact factor: 8.588

3.  Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia.

Authors:  Pedro Augusto Sampaio Rocha-Filho; João Eudes Magalhães
Journal:  Cephalalgia       Date:  2020-11       Impact factor: 6.292

4.  Sufentanil alleviates cerebral ischemia-reperfusion injury by inhibiting inflammation and protecting the blood-brain barrier in rats.

Authors:  Zhen Wang; Xiaoyan Du; Daoyang Yu; Yang Yang; Gaoen Ma; Xueli Jia; Lulu Cheng
Journal:  Eur J Histochem       Date:  2022-01-12       Impact factor: 3.188

5.  Clinical Effect of Digital Subtraction Angiography Combined with Neurointerventional Thrombolysis for Acute Ischemic Cerebrovascular Disease and Its Influence on Vascular Endothelial Function and Oxidative Stress.

Authors:  Xuna Wang; Xuesong Zhang; Qingbo Guan; Kuiyang Wang
Journal:  Oxid Med Cell Longev       Date:  2022-08-09       Impact factor: 7.310

6.  Cerebral Hemodynamics, Right-to-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls.

Authors:  Nicoletta Brunelli; Claudia Altamura; Carlo A Mallio; Gianguido Lo Vullo; Marilena Marcosano; Marcel Bach-Pages; Bruno Beomonte Zobel; Carlo Cosimo Quattrocchi; Fabrizio Vernieri
Journal:  Int J Environ Res Public Health       Date:  2022-07-14       Impact factor: 4.614

Review 7.  Migraine in transient global amnesia: a meta-analysis of observational studies.

Authors:  Ioannis Liampas; Athanasios S Siouras; Vasileios Siokas; Zisis Tsouris; Dimitrios Rikos; Alexandros Brotis; Athina-Maria Aloizou; Metaxia Dastamani; Efthimios Dardiotis
Journal:  J Neurol       Date:  2021-01-02       Impact factor: 4.849

8.  Adult Migraine Hospital Admission Trends in Finland: A Nationwide Registry Study.

Authors:  Jussi O T Sipilä; Jori O Ruuskanen; Päivi Rautava; Ville Kytö
Journal:  J Clin Med       Date:  2020-01-23       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.